| ASSET | YEAR | % RETURN |
|---|---|---|
Scienture (SCNX) | 2014 | 1,134,592.86% |
CEA Industries (CEAD) | 2014 | 156,830.69% |
PetVivo (PETV) | 2014 | 64,689.33% |
Empire Petroleum (EP) | 2014 | 1,149.38% |
Andretti Acquisition Corp II Class A Ordinary Shares (POLE) | 2014 | 896.73% |
Interlink Electronics (LINK) | 2014 | 676.42% |
GT Biopharma (GTBP) | 2014 | 626.22% |
Cyclo Therapeutics (CYTH) | 2014 | 611.9% |
Nocera (NCRA) | 2014 | 600% |
Green Brick Partners (GRBK) | 2014 | 595.33% |
GEE (JOB) | 2014 | 473.46% |
Ammo (POWW) | 2014 | 465.22% |
RadNet (RDNT) | 2014 | 408.33% |
NioCorp Developments Ltd Common Stock (NB) | 2014 | 393.65% |
Tempest Therapeutics (TPST) | 2014 | 384.34% |
INVO Bioscience (INVO) | 2014 | 381.48% |
NAYA Biosciences (NAYA) | 2014 | 381.48% |
Better Choice (BTTR) | 2014 | 375% |
Agios Pharm (AGIO) | 2014 | 371.15% |
Bluebird bio (BLUE) | 2014 | 337.59% |
Applied Digital (APLD) | 2014 | 304% |
TG Therapeutics (TGTX) | 2014 | 300% |
OneSpan (OSPN) | 2014 | 265.41% |
Amicus Therapeutics (FOLD) | 2014 | 254.04% |
Natural Health Trend (NHTC) | 2014 | 253.49% |
